Clinical trial
Lycopene in Preventing Prostate Cancer in Healthy Participants
NCT00093561 · University of Illinois at Chicago, Other · Completed
Key facts
| NCT number | NCT00093561 |
|---|---|
| Title | Lycopene in Preventing Prostate Cancer in Healthy Participants |
| Official title | Phase I Single Dose Pharmacokinetic Study of the Dietary Supplement Lycopene Delivered in Capsule Form to Healthy Male Volunteers Between 18 and 45 Years of Age |
| Lead sponsor | University of Illinois at Chicago, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Dietary Supplement |
| Interventions | lycopene |
| Start date | Aug 1, 2004 |
| Completion | Feb 1, 2006 |
| First posted | Oct 8, 2004 |
| Last update posted | Jun 26, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: